source
- CRISPR-based epigenetic editing shows promise in silencing hepatitis B genesA new CRISPR-based technique targets the epigenome to turn off genes that drive chronic hepatitis B infection, doing so without changing the underlying DNA sequence. Tune Therapeutics reported ear…
- Shionogi receives FDA nod for first oral COVID-19 post-exposure prevention pillShionogi announced that the U.S. Food and Drug Administration has granted approval for its oral antiviral designed to prevent COVID-19 after exposure. The product is indicated for adults and child…